Obacunone inhibited the cellular Akt signaling pathway; increased cancer cell DNA fragmentation, caspase-3 activity, and cytoplasmic cytochrome C levels; inhibited cell proliferation; dose-dependently and time-dependently induced apoptosis, significantly decreasing inflammatory and cancer cell marker levels in LNCaP cells. This evidence concerns the gene CYCS and cancer.